Related Experiment Video
Updated: Aug 19, 2026

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
Metabolic Changes of Perimenopause and Nutritional Advice
S L R Bonnes1, H Nordhues2, R Sood2
1Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. bonnes.sara@mayo.edu.
Purpose Of Review:
Perimenopause is a period of hormonal volatility associated with clinically relevant changes in metabolism and cardiometabolic risk. In addition to vasomotor symptoms, sleep disruption, and changes in body composition, the transition from the late reproductive years to early postmenopause is characterized by physiologic alterations that may precede formal diagnostic thresholds for metabolic syndrome. However, screening and risk stratification are often anchored to postmenopausal benchmarks, potentially delaying identification of individuals at elevated risk.
Recent Findings:
Accumulating evidence supports earlier attention to dynamic indices of cardiometabolic deterioration during perimenopause. Lifestyle interventions and, for selected individuals, menopausal hormone therapy may mitigate progression, although important uncertainties remain, including the long-term effectiveness of precision nutrition approaches and genotype-informed strategies. This narrative review summarizes physiologic changes across the menopausal transition and evaluates nutrition and lifestyle interventions that may attenuate adverse metabolic trajectories.
Related Concept Videos
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Regulation
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hypothyroidism II: Pathophysiology
Oogenesis